CANNOMED MEDICAL (Israel) Today

CANNOMED MEDICAL is trading at 62.00 as of the 26th of September 2021, a -1.59 percent decrease since the beginning of the trading day. The stock's open price was 63.0. Equity ratings for CANNOMED MEDICAL are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of August 2021 and ending today, the 26th of September 2021. Click here to learn more.
Valuation
Check how we calculate scores

CANNOMED MEDICAL Stock Profile

Cannomed Medical Cannabis Industries Ltd, a biopharmaceutical company, discovers and develops novel therapeutics. The company was founded in 1999 and is based in Rehovot, Israel. CANNOMED MEDICAL is traded on Tel Aviv Stock Exchange in Israel. more on CANNOMED MEDICAL
CANNOMED MEDICAL is not yet fully synchronised with the market data
The company reported the revenue of 17.92 M. Net Loss for the year was (8.81 M) with profit before overhead, payroll, taxes, and interest of 4.83 M.
CANNOMED MEDICAL has accumulated about 5 M in cash with (6.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06.
Roughly 51.0% of the company shares are held by company insiders
Legal NameCANNOMED MEDICAL
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of CANNOMED MEDICAL's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
CANNOMED MEDICAL (CNMD) is traded on Tel Aviv Stock Exchange in Israel and employs 50 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 69.57 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CANNOMED MEDICAL's market, we take the total number of its shares issued and multiply it by CANNOMED MEDICAL's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. CANNOMED MEDICAL operates under Healthcare sector and is part of Biotechnology industry. The entity has 99.39 M outstanding shares. CANNOMED MEDICAL has accumulated about 5 M in cash with (6.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06.
Check CANNOMED MEDICAL Probability Of Bankruptcy

CANNOMED Stock Against Markets

Picking the right benchmark for CANNOMED MEDICAL stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in CANNOMED MEDICAL stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for CANNOMED MEDICAL is critical whether you are bullish or bearish towards CANNOMED MEDICAL at a given time.

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CANNOMED MEDICAL stock to make a market-neutral strategy. Peer analysis of CANNOMED MEDICAL could also be used in its relative valuation, which is a method of valuing CANNOMED MEDICAL by comparing valuation metrics with similar companies.
Continue to Trending Equities. Note that the CANNOMED MEDICAL information on this page should be used as a complementary analysis to other CANNOMED MEDICAL's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Tools for CANNOMED Stock

When running CANNOMED MEDICAL price analysis, check to measure CANNOMED MEDICAL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CANNOMED MEDICAL is operating at the current time. Most of CANNOMED MEDICAL's value examination focuses on studying past and present price action to predict the probability of CANNOMED MEDICAL's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move CANNOMED MEDICAL's price. Additionally, you may evaluate how the addition of CANNOMED MEDICAL to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go